Experian


Healthy H1 FY20/21 performance; momentum to sustain during Q3 FY20/21

18/11/20 -"Experian performed strongly in Q2 FY20/21 (+5% yoy organic revenue; at top-end of management’s guidance), on the back of the sustained robust momentum in the US mortgage activity and consumer ..."

Pages
43
Language
English
Published on
18/11/20
You may also be interested by these reports :
02/12/20
The Security Services is effervescent with two takeover bids for the UK group G4S. On 2 December 2020, GardaWorld raised its offer price to a more ...

02/12/20
Adecco, at its CMD yesterday, unveiled the new Future@Work strategy, which will take the baton from the Perform, Transform and Innovate strategy ...

18/11/20
We have improved our estimates for Experian, following its strong H1 FY20/21 performance, which beat our expectations for both the top line and ...

18/11/20
Experian performed strongly in Q2 FY20/21 (+5% yoy organic revenue; at top-end of management’s guidance), on the back of the sustained robust ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO